Field Randomization of Nerinetide (NA-1) Therapy in Early Responders

NCT02315443 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Cerebral Ischemia

Interventions

DRUG: Nerinetide (NA-1)
DRUG: Placebo

Sponsor

NoNO Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]